INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹70 Cr | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹70 Cr |
Mar2024 | ₹56 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹20 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹70 Cr | 26.54 | |
Mar2024 | ₹56 Cr | 16.82 | |
Mar2023 | ₹48 Cr | 36.64 | |
Mar2022 | ₹35 Cr | 72.77 | |
Mar2021 | ₹20 Cr | - |
Compare Net Current Assets of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹299.4 Cr | 1.3% | -17.1% | -45.9% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,021.5 Cr | 2.3% | 1.3% | -32.8% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,095.5 Cr | 0.9% | 8.3% | 7.6% | Stock Analytics | |
VENKYS (INDIA) | ₹2,090.5 Cr | -0.9% | -1.8% | -39% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,410.5 Cr | -4.6% | -0.2% | -27% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹512.8 Cr | -1.4% | -7.7% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 1.3% |
-17.1% |
-45.9% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses